4//SEC Filing
Harmon Seth 4
Accession 0000950170-25-032884
CIK 0001590750other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 9:12 PM ET
Size
19.2 KB
Accession
0000950170-25-032884
Insider Transaction Report
Form 4
Harmon Seth
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2025-03-03+25,068→ 25,068 total→ Common Stock (25,068 underlying) - Award
Stock Option (Right to Buy)
2025-03-03+150,407→ 150,407 totalExercise: $14.41Exp: 2035-03-03→ Common Stock (150,407 underlying)
Footnotes (3)
- [F1]The option vests and becomes exercisable in 48 equal monthly installments following the date of the grant, subject to the Reporting Person's continued service to Issuer through each vesting date. The date of the grant is March 3, 2025.
- [F2]Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of the Issuer.
- [F3]The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 3, 2025, subject to the Reporting Person's continued service to Issuer through each vesting date.
Documents
Issuer
Viridian Therapeutics, Inc.\DE
CIK 0001590750
Entity typeother
Related Parties
1- filerCIK 0001993300
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 9:12 PM ET
- Size
- 19.2 KB